Trish Shamp

Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation

E.A. Cefali, P D Simmons, Eric J. Stanek et al. · International Journal of Clinical Pharmacology and Therapeutics · 2006 · 33 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Phase I Dose Escalation Study To Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis

Seth Hetherington, Michele Texter, Eric Wenzel et al. · Antimicrobial Agents and Chemotherapy · 2006 · 14 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3–1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects

C E Halstenson, Trish Shamp, Michele Gargano et al. · Investigational New Drugs · 2016 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9